Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab)

Author:

Miroddi Marco12,Sterrantino Carmelo23,Simmonds Mark1,Caridi Luigi3,Calapai Gioacchino1,Phillips Robert S.24,Stewart Lesley A.2

Affiliation:

1. Department of Biomedical and Dental Sciences and Morphofunctional Imaging; University of Messina; Messina Italy

2. Centre for Reviews and Dissemination; University of York; York United Kingdom

3. Department of Clinical and Experimental Medicine; University of Messina; Messina Italy

4. Department of Paediatric Oncology Haematology; Leeds General Infirmary; Leeds United Kingdom

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference61 articles.

1. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer;Akl;Cochrane Database Syst Rev,2014

2. Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management;Donnellan;Curr Oncol,2014

3. Cancer-associated thrombosis: an overview;Elyamany;Clin Med Insights Oncol,2014

4. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

5. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis;Horsted;PLoS Med,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3